Patient | 1 | 2 | 3 | 4 | 5 | |||
---|---|---|---|---|---|---|---|---|
Post-KT | 1st post-KT biopsy | 2nd post-KT biopsy | 3rd post-KT biopsy | Post-KT | Post-KT | 1st post-KT biopsy | 2nd post-KT biopsy | |
Scr/proteinuria at biopsy | 0.77/2.21 | 3.05/6.09 | 1.2/0.66 | 1.67/5.5 | 1.33/37.03 | |||
Treatment | Plasma exchange | None | None | Rituximab | Pulse steroid + bortezomib | Bortezomib | Sofosbuvir + Daclatasvir + pulse steroid | Bortezomib + plasma exchange |
Treatment-related complication | None | None | None | Varicella infection | None | None | ||
Follow-up timea | 13 months | 39 months | 7 months | 11 months | 1 months | |||
Last follow-up Scr(mg/dl)/Proteinuria(g/d) | Death due to pulmonary infections | In dialysis | In dialysis | 1.1/− | 1.25/14 |